{"id":28289,"date":"2022-08-22T12:00:00","date_gmt":"2022-08-22T12:00:00","guid":{"rendered":"http:\/\/aab227a76304b62b8c00b918d6474acc"},"modified":"2024-11-03T15:13:17","modified_gmt":"2024-11-03T15:13:17","slug":"esmo-congress-2022-9-13-september","status":"publish","type":"post","link":"https:\/\/ogkologos.com\/en\/esmo-congress-2022-9-13-september\/","title":{"rendered":"ESMO Congress 2022, 9-13 September"},"content":{"rendered":"<p>LUGANO, Switzerland&nbsp;\u2013&nbsp;The <a href=\"https:\/\/www.esmo.org\/meetings\/esmo-congress-2022\" class>ESMO Congress 2022<\/a> will be held in person in Paris and virtually between 9-13 September 2022.<\/p>\n<p>The congress <a href=\"https:\/\/cslide.ctimeetingtech.com\/esmo2022\/attendee\/confcal\/session\/calendar\" target=\"_blank\" rel=\"noopener noreferrer\" class>programme,<\/a> with lectures, abstract and late-breaking abstract titles, is available online.<\/p>\n<h4>Programme highlights<\/h4>\n<p>Around 2000 abstracts and late-breaking abstracts will be presented during the congress days, some of particular relevance are:<\/p>\n<ul>\n<li>Newly discovered mechanism of action for air pollution induced non-small cell lung cancer paves the way to new potential approaches to lung cancer prevention and treatment (LBA1)<\/li>\n<li>Screening for multiple cancers simultaneously with a blood test to facilitate early detection of previously hard to find cancers (903O &#8211; PATHFINDER)<\/li>\n<li>Targeting the right population with the right drug: the importance of designing rigorous randomised controlled Phase 3 trials in rare cancers to improve patients\u2019 outcomes and quality of life (LBA2 \u2013 DeFi)<\/li>\n<li>Results from Phase 3 trials with immunotherapy in:\n<ul>\n<li>Advanced melanoma (LBA3 &#8211; M14TIL)<\/li>\n<li>Localised renal cell carcinoma (LBA4 \u2013 CheckMate914) and previously untreated advanced renal cell carcinoma (LBA8 \u2013 COSMIC-313)<\/li>\n<li>Locally advanced or metastatic urothelial cancer (LBA73 &#8211; EV-103 Cohort K)<\/li>\n<li>Locally advanced head and neck squamous cell carcinoma (LBA5 \u2013 KEYNOTE-412)<\/li>\n<li>Non-small cell lung cancer non eligible for a platinum-based chemotherapy (LBA11 \u2013 IPSOS)<\/li>\n<li>Epithelial ovarian cancer (LBA30 \u2013 ATALANTE\/ov29)<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h4>Keynote lectures<\/h4>\n<ul>\n<li>\u201cWhat is the future of digital medicine for cancer patients?\u201d, Deb Schrag, Saturday 10 September at 12:00 CEST<\/li>\n<li>\u201cAntigen-focused, biotech-empowered: The promise of antibody and cell-based therapies in cancer\u201d, John Haanen and Ton Schumacher, Sunday 11 September at 12:00 CEST<\/li>\n<li>\u201cBRCA mutation\u201d, Judy Garber, Monday 12 September at 12:00 CEST<\/li>\n<\/ul>\n<h4>Official ESMO activities for journalists<\/h4>\n<p>Details of the official ESMO activities for journalists will be made available <a href=\"https:\/\/www.esmo.org\/meetings\/esmo-congress-2022\/press-media\" class>online<\/a> shortly.<\/p>\n<h4>Opening Press Conference<\/h4>\n<p>The ESMO2022 Opening Press Conference will be held in presence and via Zoom on Friday morning, 9 September, 10:30-11:15 CEST.<\/p>\n<p>Panelists:<\/p>\n<ul>\n<li>Solange Peters, CHUV &#8211; Centre Hospitalier Universitaire Vaudois, Switzerland \u2013 ESMO President<\/li>\n<li>Fabrice Andr\u00e9, Gustave Roussy Cancer Campus, France \u2013 ESMO 2022 Scientific Co-Chair<\/li>\n<li>Charles Swanton, The Francis Crick Institute, UK \u2013 ESMO 2022 Scientific Co-Chair<\/li>\n<li>Rosa Giuliani, The Clatterbridge Cancer Centre, UK\u2013 ESMO Director for Public Policy<\/li>\n<li>Antonio Passaro, IEO &#8211; Istituto Europeo di Oncologia, Italy \u2013 ESMO 2022 Press Officer<\/li>\n<li>Lena Sharp, Regionalt Cancercentrum Stockholm, Sweden &#8211; Senior Advisor European Oncology Nursing Society (EONS)<\/li>\n<\/ul>\n<p>To participate in the Opening Press Conference, media representatives must be accredited for the congress. Please submit your request for accreditation before <strong>Monday 5 September<\/strong>.<\/p>\n<h4>Embargoed press briefings<\/h4>\n<p>On Saturday, Sunday and Monday morning at 07:15 CEST, accredited media representatives are invited to attend press briefings (in presence and via Zoom), where the authors of selected studies will anticipate their data and will be available for questions.<\/p>\n<p>All press briefings will be embargoed.<\/p>\n<h4>Press releases<\/h4>\n<p>Press releases will be made available under embargo to accredited media representatives a few days ahead of the congress.<\/p>\n<h4>Media accreditation<\/h4>\n<p>ESMO welcomes media interested in reporting from the ESMO events and on cancer issues. The ESMO Press Office will consider only media accreditation requests received through the <a href=\"https:\/\/esmo.formstack.com\/forms\/media_registration_form_esmo_esmo_congress_2022\" target=\"_blank\" rel=\"noopener noreferrer\" class>ESMO Media Registration Form<\/a>. Accredited journalists will have access to the ESMO Opening Press Conference and daily briefings (as per timeline above), all congress sessions, e-posters, exhibition, industry satellite symposia, and will be able to watch the congress webcasts.<\/p>\n<p>Media representatives are required to observe and abide by the <a href=\"https:\/\/www.esmo.org\/newsroom\/esmo-media-policy\" class>ESMO Media Policy<\/a>, which applies to all ESMO events, and the <a href=\"https:\/\/www.esmo.org\/meetings\/esmo-congress-2022\/press-media\" class>embargo schedule<\/a> for the ESMO Congress 2022.<\/p>\n<h4>Further information<\/h4>\n<p>ESMO Press Office <br \/><a href=\"mailto:press@esmo.org\" target=\"_blank\" rel=\"noopener noreferrer\" class>press@esmo.org<\/a>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.esmo.org\/newsroom\/press-releases\/esmo-congress-2022-9-13-september\">Source<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>LUGANO, Switzerland&nbsp;\u2013&nbsp;The ESMO Congress 2022 will be held in person in Paris and virtually between 9-13 September 2022. The congress programme, with lectures, abstract and late-breaking abstract titles, is available online. Programme highlights Around 2000 abstracts and late-breaking abstracts will be presented during the congress days, some of particular relevance are: Newly discovered mechanism of [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[5137],"tags":[],"class_list":["post-28289","post","type-post","status-publish","format-standard","hentry","category-world-news"],"_links":{"self":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/28289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/comments?post=28289"}],"version-history":[{"count":1,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/28289\/revisions"}],"predecessor-version":[{"id":44863,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/28289\/revisions\/44863"}],"wp:attachment":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/media?parent=28289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/categories?post=28289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/tags?post=28289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}